Evidence map›Paper›PMID 40399817›Full record

ArticleBMC cancer2025

Comparison of efficacy and prognostic impact of adjuvant

Nan Sun, Mengyue Liu, Chuang Xi, Quanyong Luo, Xiaoer Wei, Zhongling Qiu

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nan Sun *Department of Nuclear Medicine, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai.600 Yi Shan Rd, Shanghai, 200233, China.
Mengyue Liu *Department of Nuclear Medicine, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai.600 Yi Shan Rd, Shanghai, 200233, China.
Chuang XiDepartment of Nuclear Medicine, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai.600 Yi Shan Rd, Shanghai, 200233, China.
Quanyong LuoDepartment of Nuclear Medicine, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai.600 Yi Shan Rd, Shanghai, 200233, China.
Xiaoer WeiDepartment of Diagnostic and Interventional Radiology, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai.600 Yi Shan Rd, Shanghai, 200233, China. weixiaoer_2003@163.com.
Zhongling QiuDepartment of Nuclear Medicine, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai.600 Yi Shan Rd, Shanghai, 200233, China. qiuzhongling123@163.com.

Funding

Clinical research project of Shanghai Municipal Health Commission 202340013
6 · The paper itself

Abstract

backgroundThe optimal dose of adjuvant radioiodine(

methodsData for eligible patients with DTC who received adjuvant

resultsIn total, 224 patients with DTC were enrolled. Six months after adjuvant

conclusionsThe efficacy of adjuvant

Indexed as

Iodine RadioisotopesThyroid NeoplasmsAdolescentAdultAgedFemaleHumansMaleMiddle AgedPrognosisRadiotherapy, AdjuvantRetrospective StudiesTreatment OutcomeYoung AdultIodine-131Iodine RadioisotopesAdjuvant therapyDifferentiated thyroid cancerDosageEfficacyRadioiodine

Identifiers

PMID40399817
PMCPMC12096512

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.